Rare Diseases and Orphan Drugs: A Life-Saving Partnership
Three decades ago, rare disease patients caused a “ruckus” and demanded Congress take action to pass the Orphan Drug Act.
Paul Melmeyer with the National Organization for Rare Disorders explains that the Orphan Drug Act has played a critical role in the development of hundreds of treatments and orphan drugs for rare diseases.
Find out more about how the Orphan Drug Act is helping patients.
Get notified about new stories and resources to empower patients and caregivers.